Proliferating cell nuclear antigen (PCNA) is an evolutionarily conserved 36 kDa nuclear protein that by functioning as a co-factor for DNA polymerase 6 is an absolute requirement for semiconservative DNA synthesis (Bravo & MacDonaldBravo, 1987; Suzuka et al., 1989; Baserga, 1991 Levison, 1990; McCormick & Hall, 1992) . The rationale for this approach is the ability of several anti-PCNA antibodies to recognise fixation-and processingresistant epitopes (Hall et al., 1990; McCormick & Hall, 1992) , thus allowing the possibility of objectively quantifying the number of cycling cells in tissue sections. One particular commercially available antibody, clone PCIO , has been widely employed in pathology in this context.
Proliferating cell nuclear antigen (PCNA) is an evolutionarily conserved 36 kDa nuclear protein that by functioning as a co-factor for DNA polymerase 6 is an absolute requirement for semiconservative DNA synthesis (Bravo & MacDonaldBravo, 1987; Suzuka et al., 1989; Baserga, 1991) . Levels of PCNA are almost negligible in long-term quiescent cells and increase dramatically during the cell cycle. Recently there has been considerable interest in the application of antibodies to PCNA as operational markers of proliferation in histological material (Hall & Levison, 1990; McCormick & Hall, 1992) . The rationale for this approach is the ability of several anti-PCNA antibodies to recognise fixation-and processingresistant epitopes (Hall et al., 1990; McCormick & Hall, 1992) , thus allowing the possibility of objectively quantifying the number of cycling cells in tissue sections. One particular commercially available antibody, clone PCIO , has been widely employed in pathology in this context. In the original description of the application of this reagent to pathological material, Hall et al. (1990) reported that, in addition to important technical caveats on its use, the number of PCIO-immunoreactive cells appeared to exceed that expected in certain situations, most notably in neoplasia. Part of the explanation for the expression of PCNA in non-cycling cells lies in the long half-life of the PCNA protein . Support for this interpretation was provided by detailed kinetic studies of tumour xenografts (Scott et al., 1991) . It has also been shown that PCNA participates in DNA repair processes. Tightly bound PCNA can be found associated with chromatin at all phases of the cell cycle after UV irradiation in vitro (Celis & Madsen, 1986; Toschi & Bravo, 1988) , and PCNA has been shown to an obligate requirement for DNA nucleotide excision repair (Shivji et al., 1992) . PCNA may be expressed by non-cycling cells in vivo which are undergoing DNA repair (Hall et al., 1993) . However, this cannot explain all the situations in which 'aberrant' PCNA expression has been observed.
In several organs, notably breast, liver and pancreas, normal tissues adjacent to tumours show high levels of PCNA expression that appears not to be associated with proliferation (Hall et al., 1990; Pelosi et al., 1992; Harrison et al., 1993) . Based upon the observations of Baserga and coworkers Ottavio et al., 1990; Baserga, 1991), Hall et al. (1990) 25 Ci mmol ', Amersham International, Amersham, UK). One hour later the animals (n = 6) were killed and xenografts growing in the liver were removed, fixed in formalin and processed to paraffin for both immunostaining and autoradiography.
It is known from previous studies that LoVo and HT-29 express growth factors similar to transforming growth factor (TGF-x) and epidermal growth factor (EGF) (Anano et al., 1989; Imanishi et al., 1989) . Therefore, in a second set of experiments, rats were given total parenteral nutrition (TPN) with or without supplements of TGF-x or EGF for 3 days, as described previously (Goodlad et al., 1987 (Goodlad et al., , 1992 . In brief, male Wistar rats (approximately 200 g) were anaesthetised with 0.7 ml of Hypnorm and 0.07 ml of diazepam (intraperitoneal route), and a silastic cannula was tied into the right external jugular vein. The cannula was connected through a stainless-steel skin button and tethered to a fluid swivel joint (SMA, Barnet, UK). The rats were housed individually in wire-bottomed cages. The TPN diet was pumped into the rats, from a refrigerator, by a multichannel peristaltic pump, at a rate of 60 ml per rat per day, giving 1.8 g of nitrogen, 6.0 g of lipid, 8.5 g of glucose and 1,047 kJ kg-' day-' (Goodlad et al., 1987) . There were three groups of 11 rats in the second study, the first being the (TPN alone) controls; the second were given 275 jg kg-' TGF-a (J. Fritton, ICI Macclesfield, Cheshire, UK) and the third were given 300 ILg kg-' EGF (M. Edwards, British Biotechnology, Cowley, Oxford, UK). One hour prior to sacrifice animals were given tritiated thymidine (1.0 iCi kg-') by i.p. injection. At the end of the experiments, animals were killed and tissues (liver and pancreas) were fixed in formalin and pro-cessed to paraffin for both immunostaining and autoradiography.
PCNA immunoreactivity was identified in both sets of experiments in the same way using the monoclonal antibody PC1O by immunohistochemistry as described previously (Hall et al., 1990) , except that the indirect method was employed (rather than ABC) because of the presence of high levels of biotin in the liver. The PC1O antibody recognises a highly conserved epitope on both human and rodent PCNA. Autoradiography was performed using standard methods (Goodlad et al., 1987 (Goodlad et al., , 1992 . In brief, sections were dehydrated in alcohols containing 300 mM ammonium acetate, dried, dipped in Ilford K5 emulsion and exposed for 6-10 days at 4C before development in Kodak D19. Sections were then counterstained lightly with haemotoxylin.
Quantitation of PCNA expression was performed on an Olympus BH2 microscope by counting positive cells (nuclear labelling) per 1,000 hepatocytes or pancreatic epithelial cells. In the pancreas the three morphologically distinct compartments, ducts, acini and islets, were enumerated separately. In the livers of animals with hepatic xenografts the labelling of hepatocytes was assessed semiquantitatively with respect to distance to xenograft in that section. Using a 20 x objective the proportion of labelled cells within two fields' distance, between three and four fields' distance and more than four fields' distance was estimated in order to give some indication of the gradient of any effect due to the xenograft.
Results
Injection of LoVo or HT29 cells into the liver gave rise to progressively growing tumour xenografts within the hepatic parenchyma. The adjacent liver cells appeared morphologically unremarkable, but many showed nuclear PCNA immunoreactivity (Figure la) , although there was little evidence of thymidine incorporation as an independent assay of cell proliferation (Figure lb) . Quantitation of PCNA immunoreactive hepatocytes and cells showing thymidine incorporation confirmed this qualitative assessment (see Table   I ). Specifically, neither HT29 nor LoVo xenografts induced any cell proliferation compared with that observed in control Isomolar concentrations of TGF-x or EGF induced upno alteration in thymidine labelling in the TGF-(x-or EGFregulation of PCNA expression in the pancreas (Figure 2a treated animals as compared with controls. In addition, there and b) as compared with control in the ductal and islet was an increase in hepatic PCNA expression compared with epithelium, but not in the acinar cells (P<O.001). There was control, although no detectable increase in thymidine incorporation (Table II) .
D ioa
It has been reported previously that, although under many circumstances PCNA expression correlates well with cell proliferation, apparent deregulation is sometimes observed, such deregulation occurring particularly in neoplasia (Hall et al., 1990; Yu et al., 1991; Gillett et al., 1992 Hall et al., 1990; Ottavio et al., 1990; ShipmanAppasamy et al., 1990; Baserga, 1991 (Figure 2 ) is primarily seen in ducts (and to a much lesser extent in islets) with no expression in acinar cells is consistent with the distribution of EGF receptor expression as demonstrated inimunohistologically (Lemoine et al., 1992) .
Recently Harrison et al. (1993) 
